Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-{gamma}

• Published in: Biochemical and biophysical research communications Vol. 348; no. 3
• Main Authors: Kanata, Sohya, Akagi, Masao, Nishimura, Shunji, Hayakawa, Sumio, Yoshida, Kohji, Sawamura, Tatsuya, Munakata, Hiroshi, Hamanishi, Chiaki
• Format: Journal Article
• Language: English
• Published: United States 29.09.2006
• Subjects: 60 APPLIED LIFE SCIENCES; ANTIBODIES; CARTILAGE; CATTLE; GROWTH FACTORS; LIPOPROTEINS; RECEPTORS
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2006.07.133

It has been reported that vascular endothelial growth factor (VEGF) and its receptors play an important role in the destruction of articular cartilage in osteoarthritis through increased production of matrix metalloproteinases. We investigated whether the oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) upregulates VEGF expression in cultured bovine articular chondrocytes (BACs). Ox-LDL markedly increased VEGF mRNA expression and protein release in time- and dose-dependent manners, which was significantly suppressed by anti-LOX-1 antibody pretreatment. Activation of peroxisome proliferator-activated receptor (PPAR)-{gamma} was evident in BACs with ox-LDL addition and was attenuated by anti-LOX-1 antibody. The specific PPAR-{gamma} inhibitor GW9662 suppressed ox-LDL-induced VEGF expression. These results suggest that the ox-LDL/LOX-1 system upregulates VEGF expression in articular cartilage, at least in part, through activation of PPAR-{gamma} and supports the hypothesis that ox-LDL is involved in cartilage degradation via LOX-1.